[Adenylate cyclase activity and cyclic nucleotide content in human adrenal tumors under Icenko-Cushing syndrome].
The adenylate cyclase activity and cyclic nucleotide content in excised human adrenal tumours (Icenko-Cushing syndrome) were determined. The experimental data were compared to those obtained for hyperplastic adrenals. All adrenal tumours under study revealed a decreased cAMP level, an increased cGMP level and a resulting decrease of the cAMP/cGMP ratio. In malignant adrenal tumours the adenylate cyclase activity was sharply increased in comparison with that in hyperplastic adrenals. In the majority of malignant tumours the adenylate cyclase response to ACTH was either altogether absent or sharply decreased. In benign adrenal tumours the basal activity of the enzyme was unchanged and the enzyme response to ACTH was essentially normal. The decrease of adenylate cyclase response to ACTH in malignant tumours is apparently not due to the impaired catalytic activity of the enzyme, since its response to stimulation by sodium fluoride remains unaffected. In some tumours (one malignant and two benign ones) a non-specific stimulation of adenylate cyclase by hormones, which are not natural activators of the enzyme was observed. It was assumed that these changes are due to the damage of hormonal receptors in adrenal tumours.
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000310:Adrenal Gland Neoplasms / Q000378:metabolism*; D000308:Adrenocortical Hyperfunction / Q000378:metabolism; D003480:Cushing Syndrome / Q000378:metabolism*; D000242:Cyclic AMP / Q000032:analysis*; D006152:Cyclic GMP / Q000032:analysis*; D006801:Humans; D007700:Kinetics; D012969:Sodium Fluoride / Q000494:pharmacology
D012969:Sodium Fluoride; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D006152:Cyclic GMP
Aktivnost' adenilattsiklazy i soderzhanie tsiklicheskikh nukleotidov v opukholiakh nadpochechnikov cheloveka pri sindrome Itsenko--Kushinga.